Gradient Investments LLC Astrazeneca PLC Transaction History
Gradient Investments LLC
- $4.99 Billion
- Q4 2025
A detailed history of Gradient Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gradient Investments LLC holds 184,445 shares of AZN stock, worth $16.5 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
184,445
Previous 15,385
1098.86%
Holding current value
$16.5 Million
Previous $1.18 Million
1297.37%
% of portfolio
0.33%
Previous 0.03%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...